Galangin suppresses RANKL‐induced osteoclastogenesis via inhibiting MAPK and NF‐κB signalling pathways

Ítems similars

• Niloticin inhibits osteoclastogenesis by blocking RANKL–RANK interaction and suppressing the AKT, MAPK, and NF-κB signaling pathways
  per: Huanhuan Xu, et al.
  Publicat: (2022-05-01)
• Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
  per: Quan, Gui-Hua, et al.
  Publicat: (2015)
• Palmitoleic Acid Inhibits RANKL-Induced Osteoclastogenesis and Bone Resorption by Suppressing NF-κB and MAPK Signalling Pathways
  per: van Heerden, Bernadette, et al.
  Publicat: (2017)
• A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF-κB pathways
  per: Liu, Ying, et al.
  Publicat: (2021)
• Myostatin Promotes Osteoclastogenesis by Regulating Ccdc50 Gene Expression and RANKL-Induced NF-κB and MAPK Pathways
  per: Zhi, Xin, et al.
  Publicat: (2020)